IFF backs probiotic strain quality over CFU counts, taps biomics to predict behavior
Amid a growing demand for probiotics, IFF underscores the importance of improving the inherent quality of strains used in supplements, rather than increasing their colony-forming units (CFU) count. CFUs are used to estimate the number of viable microbial cells in a product. Nutrition Insight meets with Dr. Arthur Ouwehand, a technical fellow at IFF, to discuss probiotic quality, research advances, and knowledge gaps. The company uses biomics to predict how a strain will behave in the human body. Biomics is the multidimensional analysis of biological data, Ouwehand explains. He says the analysis covers many aspects, such as metabolomics (analysis of metabolites), proteomics (proteins), and transcriptomics (RNA transcripts). “Biomics, in general, will not guarantee that a probiotic works, but it will help us make informed choices on what probiotic to test, for what potential health benefit,” he details.Protein, fiber & taste drive next wave of GLP-1 companion nutrition
GLP-1 consumers are eating less, but not necessarily better, caution ingredient suppliers. They see the growing prevalence of these medications driving a shift in food and beverages, sparking innovations in nutrient-dense products with protein and fiber. Moreover, they spot taste, texture, and digestive comfort as key purchasing drivers. Innova Market Insights data indicates that GLP-1 mentions in supplement launches grew by 67% from July 2023 to June 2026. New product launches are moving beyond appetite control, combining prebiotics, probiotics, fiber, berberine, botanicals, vitamins, and minerals to address satiety, metabolic health, and digestive wellness. Oobli expands sweet protein pipeline with miraculin to target metabolic health
In response to escalating metabolic health challenges, sweet proteins are gathering pace as alternatives to sugar and traditional high-intensity sweeteners. Among the companies commercializing them, Oobli is leveraging precision fermentation to produce bio-identical sweet proteins that mirror those found in rare equatorial fruits, which it says do not trigger blood glucose spikes, insulin responses, or digestive distress. Nutrition Insight speaks to Amy Chen, president and chief commercial officer of Oobli, to take a closer look at the future of sweet protein discovery, how these digest compared to standard dietary proteins, and targeted product developments in the field.Can Nitric Oxide help when you move less?
Clinically proven, patented and sustainably made: this is the nitrate ingredient your brand's claims need. Oxystorm® by Arjuna Natural, a botanical nitrate extract manufacturer, is backed by 7 published studies and OECD safety data.Download the whitepaper and give your product a science-led edge.
Technical paper brought to you by Arjuna Natural.
CPHI Milan 2026 recap: Nutrition suppliers see affordability squeeze alongside metabolic health boom
At CPHI Milan 2026, AB Biotics, Fermenta Biotech, Ingredia, Probiotical, and Select Botanical told us what buyers asked of them this year. Affordability is shaping the macro picture, while metabolic health and inflammation drive trends. Women’s health and hormone balance dominated while pharmaceutical interest in probiotics grew. They pointed to healthy longevity and holistic health approaches as the next wave of innovation.SupplySide Global 2026 preview: Biotics, protein & longevity top agenda
At SupplySide Global 2026 (Oct 28–30), exhibitors will highlight where the nutrition and food industries are heading. GLP-1 companion nutrition is expected to take center place at the event in Las Vegas, Nevada, US, from protein innovations to fiber-forward beverages for satiety and muscle preservation. Companies are spotlighting their advances in supporting longevity, women’s health, and active nutrition, while exploring new and convenient delivery formats for actives, postbiotics, and dairy and plant proteins. Settings
- Play Interval
- Slide Duration
- Thumbnail Bar Position

Latest headlines
View more
Highlighted features

HMO advancements Oct 2026
Multimedia
View more
CPHI Milan 2026: Indena champions biology over trends in delivery format choice
Stefano Togni, chief commercial officer at Indena, discussed how the industry is at the intersection of botanical science, delivery formats, and pharmaceutical rigor applied to nutraceuticals. He underscored that the biology of ingredients needs to drive format choice, not always trends. Also,...
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement





































